Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01606280 · ClinicalTrials.gov registry record
Long-term Outcomes of Patients With Primary Amyloidosis After Stem Cell Transplantation
A clinical trial of Amyloidosis, sponsored by Mayo Clinic.
- Completed
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT01606280: Completed study of Amyloidosis, sponsored by Mayo Clinic.
NCT01606280 is a study of Amyloidosis that has completed, run by Mayo Clinic. The registered enrollment target is 400 participants, below the 1,115-participant average among 28 other Amyloidosis trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01606280, a study of Amyloidosis, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
This study examines the value of stem cell transplantation in managing light chain amyloidisis.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2011-06 |
| Est. Completion | 2013-06 |
What the finished NCT01606280 record still lists
NCT01606280 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,115-participant average among 28 other Amyloidosis trials with a reported enrollment target (64% lower).
The record links to 1 condition, with Amyloidosis appearing as the primary indexed condition, and to 0 interventions.
NCT01606280 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT01606280 about?
NCT01606280 is a clinical study titled "Long-term Outcomes of Patients With Primary Amyloidosis After Stem Cell Transplantation". This study examines the value of stem cell transplantation in managing light chain amyloidisis.
What is the current status of trial NCT01606280?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2011-06. Estimated completion is 2013-06.
What conditions does trial NCT01606280 study?
This clinical trial studies the following conditions: Amyloidosis.
Who is sponsoring clinical trial NCT01606280?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01606280 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amyloidosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01606280's enrollment target sits among peer trials
400 8th of 28 higher than 21 of 28 other Amyloidosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Amyloidosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis
RECRUITING · Phase 2
-
Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry
RECRUITING
-
A Study Of Myocardial Stiffness In Amyloidosis With Magnetic Resonance Elastography
RECRUITING
-
Dietary Reporting in the Amyloidoses
RECRUITING · NA
-
Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
RECRUITING · Phase 1
-
Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia